BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 32007170)

  • 1. Deep learning for prediction of colorectal cancer outcome: a discovery and validation study.
    Skrede OJ; De Raedt S; Kleppe A; Hveem TS; Liestøl K; Maddison J; Askautrud HA; Pradhan M; Nesheim JA; Albregtsen F; Farstad IN; Domingo E; Church DN; Nesbakken A; Shepherd NA; Tomlinson I; Kerr R; Novelli M; Kerr DJ; Danielsen HE
    Lancet; 2020 Feb; 395(10221):350-360. PubMed ID: 32007170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation study.
    Kleppe A; Skrede OJ; De Raedt S; Hveem TS; Askautrud HA; Jacobsen JE; Church DN; Nesbakken A; Shepherd NA; Novelli M; Kerr R; Liestøl K; Kerr DJ; Danielsen HE
    Lancet Oncol; 2022 Sep; 23(9):1221-1232. PubMed ID: 35964620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study.
    Kather JN; Krisam J; Charoentong P; Luedde T; Herpel E; Weis CA; Gaiser T; Marx A; Valous NA; Ferber D; Jansen L; Reyes-Aldasoro CC; Zörnig I; Jäger D; Brenner H; Chang-Claude J; Hoffmeister M; Halama N
    PLoS Med; 2019 Jan; 16(1):e1002730. PubMed ID: 30677016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts.
    Fremond S; Andani S; Barkey Wolf J; Dijkstra J; Melsbach S; Jobsen JJ; Brinkhuis M; Roothaan S; Jurgenliemk-Schulz I; Lutgens LCHW; Nout RA; van der Steen-Banasik EM; de Boer SM; Powell ME; Singh N; Mileshkin LR; Mackay HJ; Leary A; Nijman HW; Smit VTHBM; Creutzberg CL; Horeweg N; Koelzer VH; Bosse T
    Lancet Digit Health; 2023 Feb; 5(2):e71-e82. PubMed ID: 36496303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatin organisation and cancer prognosis: a pan-cancer study.
    Kleppe A; Albregtsen F; Vlatkovic L; Pradhan M; Nielsen B; Hveem TS; Askautrud HA; Kristensen GB; Nesbakken A; Trovik J; Wæhre H; Tomlinson I; Shepherd NA; Novelli M; Kerr DJ; Danielsen HE
    Lancet Oncol; 2018 Mar; 19(3):356-369. PubMed ID: 29402700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiographical assessment of tumour stroma and treatment outcomes using deep learning: a retrospective, multicohort study.
    Jiang Y; Liang X; Han Z; Wang W; Xi S; Li T; Chen C; Yuan Q; Li N; Yu J; Xie Y; Xu Y; Zhou Z; Poultsides GA; Li G; Li R
    Lancet Digit Health; 2021 Jun; 3(6):e371-e382. PubMed ID: 34045003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep learning based tissue analysis predicts outcome in colorectal cancer.
    Bychkov D; Linder N; Turkki R; Nordling S; Kovanen PE; Verrill C; Walliander M; Lundin M; Haglund C; Lundin J
    Sci Rep; 2018 Feb; 8(1):3395. PubMed ID: 29467373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
    Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
    Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal recurrence scoring system for prediction of clear cell renal cell carcinoma outcome: a discovery and validation study.
    Gui CP; Chen YH; Zhao HW; Cao JZ; Liu TJ; Xiong SW; Yu YF; Liao B; Cao Y; Li JY; Huang KB; Han H; Zhang ZL; Chen WF; Jiang ZY; Gao Y; Han GP; Tang Q; Ouyang K; Qu GM; Wu JT; Guo JP; Li CX; Li PX; Liu ZP; Hsieh JT; Cai MY; Li XS; Wei JH; Luo JH
    Lancet Digit Health; 2023 Aug; 5(8):e515-e524. PubMed ID: 37393162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective analysis using deep-learning models for prediction of survival outcome and benefit of adjuvant chemotherapy in stage II/III colorectal cancer.
    Li X; Jonnagaddala J; Yang S; Zhang H; Xu XS
    J Cancer Res Clin Oncol; 2022 Aug; 148(8):1955-1963. PubMed ID: 35332389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial intelligence quantified tumour-stroma ratio is an independent predictor for overall survival in resectable colorectal cancer.
    Zhao K; Li Z; Yao S; Wang Y; Wu X; Xu Z; Wu L; Huang Y; Liang C; Liu Z
    EBioMedicine; 2020 Nov; 61():103054. PubMed ID: 33039706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep learning model for the prediction of microsatellite instability in colorectal cancer: a diagnostic study.
    Yamashita R; Long J; Longacre T; Peng L; Berry G; Martin B; Higgins J; Rubin DL; Shen J
    Lancet Oncol; 2021 Jan; 22(1):132-141. PubMed ID: 33387492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A computed tomography-based multitask deep learning model for predicting tumour stroma ratio and treatment outcomes in patients with colorectal cancer: a multicentre cohort study.
    Cui Y; Zhao K; Meng X; Mao Y; Han C; Shi Z; Yang X; Tong T; Wu L; Liu Z
    Int J Surg; 2024 May; 110(5):2845-2854. PubMed ID: 38348900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Immune Cell Populations Identified by Machine Learning in Colorectal Cancer Using Routine Hematoxylin and Eosin-Stained Sections.
    Väyrynen JP; Lau MC; Haruki K; Väyrynen SA; Dias Costa A; Borowsky J; Zhao M; Fujiyoshi K; Arima K; Twombly TS; Kishikawa J; Gu S; Aminmozaffari S; Shi S; Baba Y; Akimoto N; Ugai T; Da Silva A; Song M; Wu K; Chan AT; Nishihara R; Fuchs CS; Meyerhardt JA; Giannakis M; Ogino S; Nowak JA
    Clin Cancer Res; 2020 Aug; 26(16):4326-4338. PubMed ID: 32439699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathological Significance and Prognostic Impact of Tumor Budding in Colorectal Cancer.
    Mehta A; Goswami M; Sinha R; Dogra A
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2447-2453. PubMed ID: 30255698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction.
    Vaidya P; Bera K; Gupta A; Wang X; Corredor G; Fu P; Beig N; Prasanna P; Patil PD; Velu PD; Rajiah P; Gilkeson R; Feldman MD; Choi H; Velcheti V; Madabhushi A
    Lancet Digit Health; 2020 Mar; 2(3):e116-e128. PubMed ID: 33334576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic markers for colorectal cancer: estimating ploidy and stroma.
    Danielsen HE; Hveem TS; Domingo E; Pradhan M; Kleppe A; Syvertsen RA; Kostolomov I; Nesheim JA; Askautrud HA; Nesbakken A; Lothe RA; Svindland A; Shepherd N; Novelli M; Johnstone E; Tomlinson I; Kerr R; Kerr DJ
    Ann Oncol; 2018 Mar; 29(3):616-623. PubMed ID: 29293881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep learning-based subtyping of gastric cancer histology predicts clinical outcome: a multi-institutional retrospective study.
    Veldhuizen GP; Röcken C; Behrens HM; Cifci D; Muti HS; Yoshikawa T; Arai T; Oshima T; Tan P; Ebert MP; Pearson AT; Calderaro J; Grabsch HI; Kather JN
    Gastric Cancer; 2023 Sep; 26(5):708-720. PubMed ID: 37269416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Pathologic Analysis of Digitized Images of Colorectal Carcinoma Improves Prediction of Recurrence-Free Survival.
    Pai RK; Banerjee I; Shivji S; Jain S; Hartman D; Buchanan DD; Jenkins MA; Schaeffer DF; Rosty C; Como J; Phipps AI; Newcomb PA; Burnett-Hartman AN; Le Marchand L; Samadder NJ; Patel B; Swallow C; Lindor NM; Gallinger SJ; Grant RC; Westerling-Bui T; Conner J; Cyr DP; Kirsch R; Pai RK
    Gastroenterology; 2022 Dec; 163(6):1531-1546.e8. PubMed ID: 35985511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep learning approach to predict lymph node metastasis directly from primary tumour histology in prostate cancer.
    Wessels F; Schmitt M; Krieghoff-Henning E; Jutzi T; Worst TS; Waldbillig F; Neuberger M; Maron RC; Steeg M; Gaiser T; Hekler A; Utikal JS; von Kalle C; Fröhling S; Michel MS; Nuhn P; Brinker TJ
    BJU Int; 2021 Sep; 128(3):352-360. PubMed ID: 33706408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.